Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases

Vincent Dive*, Kumari L. Andarawewa, Anne Boulay, Magdalini Matziari, Fabrice Beau, Eric Guerin, Bernard Rousseau, Athanasios Yiotakis, Marie Christine Rio

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases'. Together they form a unique fingerprint.